SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection

SARS-CoV-2 RNA Pnl Spec NAA+probe

Definition

This panel contains results for the detection of Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), initially known as 2019-Novel Coronavirus (2019-nCoV), in various specimens, including respiratory and serum, using nucleic acid amplification assays with probe-based detection for the diagnosis of Coronavirus Disease 2019 (COVID-19). Various assays have been developed that contain primer-probe sets targeting regions of the SARS-CoV-2 genome, including regions in the RdRp, N, and E genes. [https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance] The CDC-developed SARS-CoV-2 assay contains primer and probe sets designed for specific detection of SARS-CoV-2 (N1 and N2 assays) as well as detection of the SARS-like coronaviruses (N3 assay).[CDC: coronavirus/2019-nCoV/lab/]

2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Pan; PANEL.MICROBIOLOGY; Panl; PCR; PH; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Public Health; PublicHealth; QBR; Random; Ribonucleic acid; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 RNA Pnl; SDA; Severe Acute Respiratory Syndrome; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Viral Pneumonias; Wuhan coronavirus

20 further terms